Literature DB >> 23563826

Factors of poor prognosis of visceral leishmaniasis among children under 12 years of age. A retrospective monocentric study in Belo Horizonte, State of Minas Gerais, Brazil, 2001-2005.

Alexandre Sérgio da Costa Braga1, Antonio Carlos de Castro Toledo Junior, Ana Rabello.   

Abstract

INTRODUCTION: A major concern with the visceral leishmaniasis (VL) is its high lethality rate, even with proper treatment. Low age, prior malnutrition, disease duration prior to diagnosis, severe anemia, fever for more than 60 days, diarrhea and jaundice are known poor prognostic factors. The goals of this study are to describe the clinical and laboratory characteristics of VL among children under 12 years of age and to identify the factors associated with VL poor outcome.
METHODS: Two hundred and fifty children under 12 years of age with confirmed VL admitted to Hospital João Paulo II (FHEMIG), Belo Horizonte, Brazil, between January 2001 and December 2005 were evaluated retrospectively. The primary outcome was the poor clinical evolution: sepsis, and/or pneumonia, and/or urinary tract infection, and/or of bleeding (expect epistaxis), and/or severe neutropenia (neutrophil < 500 cells/mm3). Odds ratio (crude and adjusted) and its 95% confidence interval for each variable were calculated. Values less than 0.05 were considered significant.
RESULTS: Average age was 3.3 years (3.6 months-11.6 years), 71.2% were younger than 5 years and 47.2% lived in Metropolitan Area of Belo Horizonte. The mean fatality rate was 3.6%. Sixty-six (26.4%) patients presented poor evolution. After a multivariate analysis, age <18 months, abnormal respiratory physical examination on hospital admission, and platelets <85,000/mm3 remained associated with increased chance of poor evolution.
CONCLUSIONS: The results suggest that patients aged between 12 and 18 months, with platelet counts below 85,000/mm3, and respiratory abnormalities at admission should be considered potentially severe.

Entities:  

Mesh:

Year:  2013        PMID: 23563826     DOI: 10.1590/0037-868216432013

Source DB:  PubMed          Journal:  Rev Soc Bras Med Trop        ISSN: 0037-8682            Impact factor:   1.581


  15 in total

Review 1.  Prevalence, severity, and pathogeneses of anemia in visceral leishmaniasis.

Authors:  Yasuyuki Goto; Jingjie Cheng; Satoko Omachi; Ayako Morimoto
Journal:  Parasitol Res       Date:  2016-11-07       Impact factor: 2.289

2.  Clinical characteristics and spatial distribution of Visceral leishmaniasis in children in São Paulo state: an emerging focus of Visceral leishmaniasis in Brazil.

Authors:  Patricia Rodrigues Naufal Spir; Luiz Euribel Prestes-Carneiro; Elivelton Silva Fonseca; Aline Dayse; Rogério Giuffrida; Lourdes Aparecida Zampieri D'Andrea
Journal:  Pathog Glob Health       Date:  2017-02-21       Impact factor: 2.894

3.  Late diagnosis: a factor associated with death from visceral leishmaniasis in elderly patients.

Authors:  Marta Driemeier; Polliana Alvarenga de Oliveira; Angelita Fernandes Druzian; Laís Ferreira Lopes Brum; Elenir Rose Jardim Cury Pontes; Maria Elizabeth Cavalheiros Dorval; Anamaria Mello Miranda Paniago
Journal:  Pathog Glob Health       Date:  2015-08-10       Impact factor: 2.894

4.  Human visceral leishmaniasis: factors associated with deaths in Belo Horizonte, Minas Gerais state, Brazil from 2006 to 2013.

Authors:  F R P Bruhn; M H F Morais; N C P Bruhn; D L Cardoso; F Ferreira; C M B M Rocha
Journal:  Epidemiol Infect       Date:  2018-02-21       Impact factor: 4.434

5.  Parasite load and risk factors for poor outcome among children with visceral leishmaniasis. A cohort study in Belo Horizonte, Brazil, 2010-2011.

Authors:  Maria Vitória Assumpção Mourão; Antonio Toledo; Luciana Inácia Gomes; Verônica Vieira Freire; Ana Rabello
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-03-04       Impact factor: 2.743

6.  Prognostic factors and scoring system for death from visceral leishmaniasis: an historical cohort study in Brazil.

Authors:  Wendel Coura-Vital; Valdelaine Etelvina Miranda de Araújo; Ilka Afonso Reis; Frederico Figueiredo Amancio; Alexandre Barbosa Reis; Mariângela Carneiro
Journal:  PLoS Negl Trop Dis       Date:  2014-12-11

7.  Clinical Features and Laboratory Findings of Visceral Leishmaniasis in Children Referred To Children Medical Center Hospital, Tehran, Iran during 2004-2011.

Authors:  Azam Tofighi Naeem; Shima Mahmoudi; Farah Saboui; Homa Hajjaran; Babak Pourakbari; Mehdi Mohebali; Mohammad Reza Zarkesh; Setareh Mamishi
Journal:  Iran J Parasitol       Date:  2014-03       Impact factor: 1.012

8.  Risk factors for mortality of children with zoonotic visceral leishmaniasis in Central Tunisia.

Authors:  Khaled Ben Helel; Mohamed Ben Rejeb; Zakia Habboul; Nizar Khattat; Houssain Mejaouel; Houyem Said-Latiri; Belhassen Kaabi; Elyes Zhioua
Journal:  PLoS One       Date:  2017-12-29       Impact factor: 3.240

9.  Visceral leishmaniasis in a Brazilian endemic area: an overview of occurrence, HIV coinfection and lethality.

Authors:  João Gabriel Guimarães Luz; Danilo Bueno Naves; Amanda Gabriela de Carvalho; Gilvani Alves Meira; João Victor Leite Dias; Cor Jesus Fernandes Fontes
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2018-03-08       Impact factor: 1.846

10.  Leishmania-HIV co-infection: clinical presentation and outcomes in an urban area in Brazil.

Authors:  Gláucia F Cota; Marcos R de Sousa; Andrea Laender Pessoa de Mendonça; Allan Patrocinio; Luiza Siqueira Assunção; Sidnei Rodrigues de Faria; Ana Rabello
Journal:  PLoS Negl Trop Dis       Date:  2014-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.